Civica Rx, a non-profit generic drug maker backed by hospitals, insurers and philanthropies, announced Thursday that it plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval.

(SOURCE) https://www.cnn.com/2022/03/03/politics/civica-insulin-affordable-drug/index.html